ADLER RHEUMATOLOGY LIMITED

💤Zombieactive
08732470 · ltd · incorporated 2013-10-15
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Oct 2025
Net worth
£4.7k
book net assets
Opportunity
73/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Hospital activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (76/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (2 active, 3 linked, 1 with DOB)
77
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
42 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
73/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Positive net assets
Net assets £4,679

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
£5k
↑ 16% YoY
Current Assets
£63k
↓ 6.2% YoY
Current Liabilities
£0£13k£27k£40k£53k£67kOct 2024Oct 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-10-312024-10-31
Total assets£4.7k£4.0k
Current assets£62.5k£66.7k
Net assets£4.7k£4.0k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
4
filings
  • 2 persons-with-significant-control
  • 2 officers
Last 180 days
5
filings
  • 2 persons-with-significant-control
  • 2 officers
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (23 events)Click to expand
  1. 2026-04-22
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  2. 2026-04-22
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  3. 2026-04-22
    📄
    change-person-director-company-with-change-date
    officers · CH01
  4. 2026-04-22
    📄
    change-person-secretary-company-with-change-date
    officers · CH03
  5. 2026-02-10
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  6. 2024-12-09
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  7. 2024-10-17
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  8. 2024-02-26
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  9. 2023-03-21
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  10. 2022-07-14
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  11. 2022-06-23
    📄
    change-person-director-company-with-change-date
    officers · CH01
  12. 2022-06-23
    📄
    change-person-secretary-company-with-change-date
    officers · CH03
  13. 2022-06-23
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  14. 2022-06-23
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  15. 2022-05-27
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  16. 2021-07-13
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  17. 2020-07-10
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  18. 2019-06-28
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  19. 2014-10-01
    ADLER, Ulla-Maija appointed
    secretary
  20. 2014-10-01
    ADLER, Dr Matthew Alexander appointed
    secretary
  21. 2014-10-01
    ADLER, Dr Matthew Alexander resigned
    secretary
  22. 2013-10-15
    🏢
    Company incorporated
    As ADLER RHEUMATOLOGY LIMITED
  23. 2013-10-15
    ADLER, Matthew Alexander, Dr appointed
    director

Owner dependency

90/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Founder name in company name: Company name contains director surname "ADLER" — strong identity link between founder and business.

Succession & seller-readiness

58/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • secondary12+ year tenure: Director in role 13 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Dr Matthew Alexander Adler
Individual · British · DOB 08/1971 · age 55
2550%
75–100%board control75-100% shares · 75-100% voting · board control06/04/2016
Ulla-Maija Adler
Individual · Finnish · DOB 05/1972 · age 54
2550%
25-50% shares06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · E postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A&H GUPTA LTD
13207341 · est 2021 · no financials extracted
5y
ADVENT COMMUNITY ASSOCIATION (NEWHAM)
03638544 · est 1998 · no financials extracted
27y
ADVICE DOCTOR LIMITED
05217720 · est 2004 · no financials extracted
21y
ADWOAMANSAH85 LIMITED
15191922 · est 2023 · no financials extracted
2y
AEGEAN COUNSELLING LTD
13475724 · est 2021 · no financials extracted
4y
AELKEMI OF SOMA LTD
16335307 · est 2025 · no financials extracted
1y
AERISOUND LTD
15780661 · est 2024 · no financials extracted
1y
AEROTOP LIMITED
06686782 · est 2008 · no financials extracted
17y
AESTHETIC & HEALTH BY FRANCYS LTD
13992291 · est 2022 · no financials extracted
4y
AESTHETIC ART ACADEMY LTD
10320205 · est 2016 · no financials extracted
9y
AESTHETICA 360 LTD
12218755 · est 2019 · no financials extracted
6y
AESTHETICS BY MAYA LIMITED
14349263 · est 2022 · no financials extracted
3y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2013-10-15
Jurisdictionengland-wales
Primary SIC86101 — Hospital activities

Registered office

16 Beaufort Court Admirals Way
Canary Wharf
London
E14 9XL
United Kingdom

Filing status

Accounts
Next due: 2027-07-31
Last made up to: 2025-10-31
Confirmation statement
Next due: 2026-10-14
Last: 2025-09-30

Officers (2 active · 1 resigned)

ADLER, Ulla-Maija
secretary · appointed 2014-10-01
View their other companies + combined net worth →
Active
ADLER, Matthew Alexander, Dr
director · ~55y · appointed 2013-10-15
View their other companies + combined net worth →
Active
ADLER, Dr Matthew Alexander
secretary · appointed 2014-10-01 · resigned 2014-10-01
Resigned

Click a director name to see their full track record across all companies.

Recent filings (42 total)

change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-04-22
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-04-22
change-person-director-company-with-change-date
officers · CH01
2026-04-22
change-person-secretary-company-with-change-date
officers · CH03
2026-04-22
accounts-with-accounts-type-micro-entity
accounts · AA
2026-02-10
confirmation-statement-with-updates
confirmation-statement · CS01
2025-10-01
accounts-with-accounts-type-micro-entity
accounts · AA
2024-12-09
confirmation-statement-with-updates
confirmation-statement · CS01
2024-10-17
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2024-10-17
accounts-with-accounts-type-micro-entity
accounts · AA
2024-02-26
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-11-17
accounts-with-accounts-type-micro-entity
accounts · AA
2023-03-21
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-10-19
accounts-with-accounts-type-micro-entity
accounts · AA
2022-07-14
change-person-director-company-with-change-date
officers · CH01
2022-06-23